| Year |
Citation |
Score |
| 2020 |
Tucker CG, Mitchell JS, Martinov T, Burbach BJ, Beura LK, Wilson JC, Dwyer AJ, Singh LM, Mescher MF, Fife BT. Adoptive T Cell Therapy with IL-12-Preconditioned Low-Avidity T Cells Prevents Exhaustion and Results in Enhanced T Cell Activation, Enhanced Tumor Clearance, and Decreased Risk for Autoimmunity. Journal of Immunology (Baltimore, Md. : 1950). PMID 32737148 DOI: 10.4049/Jimmunol.2000007 |
0.631 |
|
| 2019 |
Anderson KL, Snyder KM, Ito D, Lins DC, Mills LJ, Weiskopf K, Ring NG, Ring AM, Shimizu Y, Mescher MF, Weissman IL, Modiano JF. Evolutionarily conserved resistance to phagocytosis observed in melanoma cells is insensitive to upregulation of pro-phagocytic signals and to CD47 blockade. Melanoma Research. PMID 31205227 DOI: 10.1097/Cmr.0000000000000629 |
0.546 |
|
| 2019 |
Anderson KL, Snyder KM, Ito D, Lins DC, Mills LJ, Weiskopf K, Ring NG, Ring AM, Shimizu Y, Mescher MF, Weissman IL, Modiano JF. Abstract A051: Melanoma displays an evolutionarily conserved resistance to upregulation of prophagocytic signals and to CD47 blockade Cancer Immunology Research. 7. DOI: 10.1158/2326-6074.Cricimteatiaacr18-A051 |
0.558 |
|
| 2017 |
Anderson KL, Snyder KM, Lins D, Weiskopf K, Shimizu Y, Weissman I, Mescher M, Modiano J. Abstract A65: Mechanisms of melanoma cell resistance to phagocytosis Cancer Immunology Research. 5. DOI: 10.1158/2326-6074.Tumimm16-A65 |
0.521 |
|
| 2016 |
Anderson KL, Lins D, Volkmer J, Shimizu Y, Weissman IL, Mescher M, Modiano J. Abstract A143: Melanoma cell resistance to phagocytosis is unrelated to expression of conventional “eat-me/don't eat-me” signals Cancer Immunology Research. 4. DOI: 10.1158/2326-6074.Cricimteatiaacr15-A143 |
0.566 |
|
| 2014 |
Jha G, Miller JS, Curtsinger JM, Zhang Y, Mescher MF, Dudek AZ. Randomized phase II study of IL-2 with or without an allogeneic large multivalent immunogen vaccine for the treatment of stage IV melanoma. American Journal of Clinical Oncology. 37: 261-5. PMID 23241505 DOI: 10.1097/COC.0b013e318277d5c8 |
0.34 |
|
| 2014 |
Anderson KL, Ito D, Lins DC, Curtsinger JM, Mescher MF, Modiano JF. Abstract 4082: CD47 blockade to enhance adaptive anti-tumor immune responses Cancer Research. 74: 4082-4082. DOI: 10.1158/1538-7445.Am2014-4082 |
0.602 |
|
| 2013 |
Zumwalde NA, Domae E, Mescher MF, Shimizu Y. ICAM-1-dependent homotypic aggregates regulate CD8 T cell effector function and differentiation during T cell activation. Journal of Immunology (Baltimore, Md. : 1950). 191: 3681-93. PMID 23997225 DOI: 10.4049/Jimmunol.1201954 |
0.633 |
|
| 2013 |
Wang Y, Shaked I, Stanford SM, Zhou W, Curtsinger JM, Mikulski Z, Shaheen ZR, Cheng G, Sawatzke K, Campbell AM, Auger JL, Bilgic H, Shoyama FM, Schmeling DO, Balfour HH, ... ... Mescher MF, et al. The autoimmunity-associated gene PTPN22 potentiates toll-like receptor-driven, type 1 interferon-dependent immunity. Immunity. 39: 111-22. PMID 23871208 DOI: 10.1016/J.Immuni.2013.06.013 |
0.309 |
|
| 2013 |
Gerner MY, Heltemes-Harris LM, Fife BT, Mescher MF. Cutting edge: IL-12 and type I IFN differentially program CD8 T cells for programmed death 1 re-expression levels and tumor control. Journal of Immunology (Baltimore, Md. : 1950). 191: 1011-5. PMID 23804712 DOI: 10.4049/Jimmunol.1300652 |
0.811 |
|
| 2012 |
Curtsinger JM, Agarwal P, Lins DC, Mescher MF. Autocrine IFN-γ promotes naive CD8 T cell differentiation and synergizes with IFN-α to stimulate strong function. Journal of Immunology (Baltimore, Md. : 1950). 189: 659-68. PMID 22706089 DOI: 10.4049/Jimmunol.1102727 |
0.771 |
|
| 2012 |
Mescher MF, Curtsinger JM. Artificial antigen-presenting Cells: Large multivalent immunogens Vaccinology: Principles and Practice. 286-299. DOI: 10.1002/9781118345313.ch19 |
0.309 |
|
| 2011 |
Henson MS, Curtsinger JM, Larson VS, Klausner JS, Modiano JF, Mescher MF, Miller JS. Immunotherapy with autologous tumour antigen-coated microbeads (large multivalent immunogen), IL-2 and GM-CSF in dogs with spontaneous B-cell lymphoma. Veterinary and Comparative Oncology. 9: 95-105. PMID 21569195 DOI: 10.1111/J.1476-5829.2010.00234.X |
0.528 |
|
| 2011 |
Dings RP, Vang KB, Castermans K, Popescu F, Zhang Y, Oude Egbrink MG, Mescher MF, Farrar MA, Griffioen AW, Mayo KH. Enhancement of T-cell-mediated antitumor response: angiostatic adjuvant to immunotherapy against cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 17: 3134-45. PMID 21252159 DOI: 10.1158/1078-0432.Ccr-10-2443 |
0.795 |
|
| 2010 |
Curtsinger JM, Mescher MF. Inflammatory cytokines as a third signal for T cell activation. Current Opinion in Immunology. 22: 333-40. PMID 20363604 DOI: 10.1016/J.Coi.2010.02.013 |
0.637 |
|
| 2009 |
Agarwal P, Raghavan A, Nandiwada SL, Curtsinger JM, Bohjanen PR, Mueller DL, Mescher MF. Gene regulation and chromatin remodeling by IL-12 and type I IFN in programming for CD8 T cell effector function and memory. Journal of Immunology (Baltimore, Md. : 1950). 183: 1695-704. PMID 19592655 DOI: 10.4049/Jimmunol.0900592 |
0.713 |
|
| 2009 |
Xiao Z, Casey KA, Jameson SC, Curtsinger JM, Mescher MF. Programming for CD8 T cell memory development requires IL-12 or type I IFN. Journal of Immunology (Baltimore, Md. : 1950). 182: 2786-94. PMID 19234173 DOI: 10.4049/Jimmunol.0803484 |
0.811 |
|
| 2009 |
Gerner MY, Mescher MF. Antigen processing and MHC-II presentation by dermal and tumor-infiltrating dendritic cells. Journal of Immunology (Baltimore, Md. : 1950). 182: 2726-37. PMID 19234167 DOI: 10.4049/Jimmunol.0803479 |
0.782 |
|
| 2008 |
Gerner MY, Casey KA, Mescher MF. Defective MHC class II presentation by dendritic cells limits CD4 T cell help for antitumor CD8 T cell responses. Journal of Immunology (Baltimore, Md. : 1950). 181: 155-64. PMID 18566380 DOI: 10.4049/Jimmunol.181.1.155 |
0.862 |
|
| 2008 |
Hammerbeck CD, Mescher MF. Antigen controls IL-7R alpha expression levels on CD8 T cells during full activation or tolerance induction. Journal of Immunology (Baltimore, Md. : 1950). 180: 2107-16. PMID 18250416 DOI: 10.4049/Jimmunol.180.4.2107 |
0.852 |
|
| 2008 |
Gerner MY, Casey KA, Mescher MF. Dendritic cell tumor‐antigen processing and activation of tumor‐specific T cells The Faseb Journal. 22: 527-527. DOI: 10.1096/Fasebj.22.2_Supplement.527 |
0.827 |
|
| 2007 |
Xiao Z, Mescher MF, Jameson SC. Detuning CD8 T cells: down-regulation of CD8 expression, tetramer binding, and response during CTL activation. The Journal of Experimental Medicine. 204: 2667-77. PMID 17954566 DOI: 10.1084/Jem.20062376 |
0.635 |
|
| 2007 |
Mescher MF, Popescu FE, Gerner M, Hammerbeck CD, Curtsinger JM. Activation-induced non-responsiveness (anergy) limits CD8 T cell responses to tumors. Seminars in Cancer Biology. 17: 299-308. PMID 17656106 DOI: 10.1016/J.Semcancer.2007.06.008 |
0.845 |
|
| 2007 |
Casey KA, Mescher MF. IL-21 promotes differentiation of naive CD8 T cells to a unique effector phenotype. Journal of Immunology (Baltimore, Md. : 1950). 178: 7640-8. PMID 17548600 DOI: 10.4049/Jimmunol.178.12.7640 |
0.836 |
|
| 2007 |
Xiao Z, Curtsinger JM, Prlic M, Jameson SC, Mescher MF. The CD8 T cell response to vaccinia virus exhibits site-dependent heterogeneity of functional responses. International Immunology. 19: 733-43. PMID 17545279 DOI: 10.1093/Intimm/Dxm039 |
0.624 |
|
| 2007 |
Curtsinger JM, Gerner MY, Lins DC, Mescher MF. Signal 3 availability limits the CD8 T cell response to a solid tumor. Journal of Immunology (Baltimore, Md. : 1950). 178: 6752-60. PMID 17513722 DOI: 10.4049/Jimmunol.178.11.6752 |
0.812 |
|
| 2007 |
Mescher MF, Agarwal P, Casey KA, Hammerbeck CD, Xiao Z, Curtsinger JM. Molecular basis for checkpoints in the CD8 T cell response: tolerance versus activation. Seminars in Immunology. 19: 153-61. PMID 17382557 DOI: 10.1016/J.Smim.2007.02.007 |
0.863 |
|
| 2006 |
Mescher MF, Curtsinger JM, Agarwal P, Casey KA, Gerner M, Hammerbeck CD, Popescu F, Xiao Z. Signals required for programming effector and memory development by CD8+ T cells. Immunological Reviews. 211: 81-92. PMID 16824119 DOI: 10.1111/J.0105-2896.2006.00382.X |
0.82 |
|
| 2005 |
Curtsinger JM, Lins DC, Johnson CM, Mescher MF. Signal 3 tolerant CD8 T cells degranulate in response to antigen but lack granzyme B to mediate cytolysis. Journal of Immunology (Baltimore, Md. : 1950). 175: 4392-9. PMID 16177080 DOI: 10.4049/Jimmunol.175.7.4392 |
0.689 |
|
| 2005 |
Filatenkov AA, Jacovetty EL, Fischer UB, Curtsinger JM, Mescher MF, Ingulli E. CD4 T cell-dependent conditioning of dendritic cells to produce IL-12 results in CD8-mediated graft rejection and avoidance of tolerance. Journal of Immunology (Baltimore, Md. : 1950). 174: 6909-17. PMID 15905533 DOI: 10.4049/Jimmunol.174.11.6909 |
0.679 |
|
| 2005 |
Curtsinger JM, Valenzuela JO, Agarwal P, Lins D, Mescher MF. Type I IFNs provide a third signal to CD8 T cells to stimulate clonal expansion and differentiation. Journal of Immunology (Baltimore, Md. : 1950). 174: 4465-9. PMID 15814665 DOI: 10.4049/Jimmunol.174.8.4465 |
0.844 |
|
| 2005 |
Valenzuela JO, Hammerbeck CD, Mescher MF. Cutting edge: Bcl-3 up-regulation by signal 3 cytokine (IL-12) prolongs survival of antigen-activated CD8 T cells. Journal of Immunology (Baltimore, Md. : 1950). 174: 600-4. PMID 15634875 DOI: 10.4049/Jimmunol.174.2.600 |
0.843 |
|
| 2004 |
Oosten LE, Blokland E, van Halteren AG, Curtsinger J, Mescher MF, Falkenburg JH, Mutis T, Goulmy E. Artificial antigen-presenting constructs efficiently stimulate minor histocompatibility antigen-specific cytotoxic T lymphocytes. Blood. 104: 224-6. PMID 15031203 DOI: 10.1182/Blood-2003-07-2461 |
0.533 |
|
| 2004 |
Mitchell MS, Kan-Mitchell J, Morrow PR, Darrah D, Jones VE, Mescher MF. Phase I trial of large multivalent immunogen derived from melanoma lysates in patients with disseminated melanoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 10: 76-83. PMID 14734454 DOI: 10.1158/1078-0432.Ccr-0689-3 |
0.304 |
|
| 2003 |
Curtsinger JM, Johnson CM, Mescher MF. CD8 T cell clonal expansion and development of effector function require prolonged exposure to antigen, costimulation, and signal 3 cytokine. Journal of Immunology (Baltimore, Md. : 1950). 171: 5165-71. PMID 14607916 DOI: 10.4049/Jimmunol.171.10.5165 |
0.596 |
|
| 2003 |
Curtsinger JM, Lins DC, Mescher MF. Signal 3 determines tolerance versus full activation of naive CD8 T cells: dissociating proliferation and development of effector function. The Journal of Experimental Medicine. 197: 1141-51. PMID 12732656 DOI: 10.1084/Jem.20021910 |
0.577 |
|
| 2003 |
Goldberg J, Shrikant P, Mescher MF. In vivo augmentation of tumor-specific CTL responses by class I/peptide antigen complexes on microspheres (large multivalent immunogen). Journal of Immunology (Baltimore, Md. : 1950). 170: 228-35. PMID 12496404 DOI: 10.4049/Jimmunol.170.1.228 |
0.482 |
|
| 2002 |
Valenzuela J, Schmidt C, Mescher MF. The roles of IL-12 in providing a third signal for clonal expansion of naive CD8 T cells Journal of Immunology. 169: 6842-6849. PMID 12471116 DOI: 10.4049/Jimmunol.169.12.6842 |
0.847 |
|
| 2002 |
Harmala LA, Ingulli EG, Curtsinger JM, Lucido MM, Schmidt CS, Weigel BJ, Blazar BR, Mescher MF, Pennell CA. The adjuvant effects of Mycobacterium tuberculosis heat shock protein 70 result from the rapid and prolonged activation of antigen-specific CD8+ T cells in vivo. Journal of Immunology (Baltimore, Md. : 1950). 169: 5622-9. PMID 12421941 DOI: 10.4049/Jimmunol.169.10.5622 |
0.796 |
|
| 2002 |
Tham EL, Mescher MF. The poststimulation program of CD4 versus CD8 T cells (death versus activation-induced nonresponsiveness). Journal of Immunology (Baltimore, Md. : 1950). 169: 1822-8. PMID 12165505 DOI: 10.4049/Jimmunol.169.4.1822 |
0.881 |
|
| 2002 |
Shrikant P, Mescher MF. Opposing effects of IL-2 in tumor immunotherapy: promoting CD8 T cell growth and inducing apoptosis. Journal of Immunology (Baltimore, Md. : 1950). 169: 1753-9. PMID 12165496 DOI: 10.4049/Jimmunol.169.4.1753 |
0.574 |
|
| 2002 |
Schmidt CS, Mescher MF. Peptide antigen priming of naive, but not memory, CD8 T cells requires a third signal that can be provided by IL-12. Journal of Immunology (Baltimore, Md. : 1950). 168: 5521-9. PMID 12023347 DOI: 10.4049/Jimmunol.168.11.5521 |
0.837 |
|
| 2002 |
Tham EL, Shrikant P, Mescher MF. Activation-induced nonresponsiveness: a Th-dependent regulatory checkpoint in the CTL response. Journal of Immunology (Baltimore, Md. : 1950). 168: 1190-7. PMID 11801654 DOI: 10.4049/Jimmunol.168.3.1190 |
0.875 |
|
| 2001 |
Jensen PL, Mescher MF. Role of phosphoinositide 3-kinase in TCR-signaled regulation of CD8-mediated adhesion to class I MHC protein European Journal of Immunology. 31: 3612-3621. PMID 11745381 DOI: 10.1002/1521-4141(200112)31:12<3612::Aid-Immu3612>3.0.Co;2-J |
0.465 |
|
| 2001 |
Tham EL, Mescher MF. Signaling alterations in activation-induced nonresponsive CD8 T cells. Journal of Immunology (Baltimore, Md. : 1950). 167: 2040-8. PMID 11489986 DOI: 10.4049/Jimmunol.167.4.2040 |
0.868 |
|
| 2001 |
Ni HT, Deeths MJ, Mescher MF. LFA-1-mediated costimulation of CD8+ T cell proliferation requires phosphatidylinositol 3-kinase activity1 Journal of Immunology. 166: 6523-6529. PMID 11359803 DOI: 10.4049/Jimmunol.166.11.6523 |
0.602 |
|
| 2001 |
Kieper WC, Prlic M, Schmidt CS, Mescher MF, Jameson SC. Il-12 enhances CD8 T cell homeostatic expansion. Journal of Immunology (Baltimore, Md. : 1950). 166: 5515-21. PMID 11313390 DOI: 10.4049/Jimmunol.166.9.5515 |
0.822 |
|
| 2001 |
Tham EL, Jensen PL, Mescher MF. Activation of antigen-specific T cells by artificial cell constructs having immobilized multimeric peptide-class I complexes and recombinant B7-Fc proteins. Journal of Immunological Methods. 249: 111-9. PMID 11226469 DOI: 10.1016/S0022-1759(00)00335-5 |
0.835 |
|
| 1999 |
Shrikant P, Khoruts A, Mescher MF. CTLA-4 blockade reverses CD8+ T cell tolerance to tumor by a CD4+ T cell- and IL-2-dependent mechanism Immunity. 11: 483-493. PMID 10549630 DOI: 10.1016/S1074-7613(00)80123-5 |
0.662 |
|
| 1999 |
Schmidt CS, Mescher MF. Adjuvant effect of IL-12: conversion of peptide antigen administration from tolerizing to immunizing for CD8+ T cells in vivo. Journal of Immunology (Baltimore, Md. : 1950). 163: 2561-7. PMID 10452994 |
0.762 |
|
| 1999 |
Deeths MJ, Kedl RM, Mescher MF. CD8+ T cells become nonresponsive (anergic) following activation in the presence of costimulation Journal of Immunology. 163: 102-110. PMID 10384105 |
0.654 |
|
| 1999 |
Ni HT, Deeths MJ, Li W, Mueller DL, Mescher MF. Signaling pathways activated by leukocyte function-associated Ag-1- dependent costimulation Journal of Immunology. 162: 5183-5189. PMID 10227991 |
0.526 |
|
| 1999 |
Curtsinger JM, Schmidt CS, Mondino A, Lins DC, Kedl RM, Jenkins MK, Mescher MF. Inflammatory cytokines provide a third signal for activation of naive CD4+ and CD8+ T cells. Journal of Immunology (Baltimore, Md. : 1950). 162: 3256-62. PMID 10092777 |
0.82 |
|
| 1999 |
Shrikant P, Mescher MF. Control of syngeneic tumor growth by activation of CD8+ T cells: Efficacy is limited by migration away from the site and induction of nonresponsiveness Journal of Immunology. 162: 2858-2866. PMID 10072534 |
0.479 |
|
| 1999 |
Deeths MJ, Mescher MF. ICAM-1 and B7-1 provide similar but distinct costimulation for CD8+ T cells, while CD4+ T cells are poorly costimulated by ICAM-1 European Journal of Immunology. 29: 45-53. PMID 9933085 DOI: 10.1002/(Sici)1521-4141(199901)29:01<45::Aid-Immu45>3.0.Co;2-I |
0.677 |
|
| 1998 |
Kedl RM, Mescher MF. Qualitative differences between naive and memory T cells make a major contribution to the more rapid and efficient memory CD8+ T cell response Journal of Immunology. 161: 674-683. PMID 9670942 |
0.412 |
|
| 1998 |
Curtsinger JM, Lins DC, Mescher MF. CD8+ memory T cells (CD44(high), Ly-6C+) are more sensitive than naive cells (CD44(low), Ly-6C-) to TCR/CD8 signaling in response to antigen Journal of Immunology. 160: 3236-3243. PMID 9531279 |
0.511 |
|
| 1997 |
Curtsinger J, Deeths MJ, Pease P, Mescher MF. Artificial cell surface constructs for studying receptor-ligand contributions to lymphocyte activation Journal of Immunological Methods. 209: 47-57. PMID 9448033 DOI: 10.1016/S0022-1759(97)00146-4 |
0.495 |
|
| 1997 |
Ybarrondo B, O'Rourke AM, Mccarthy JB, Mescher MF. Cytotoxic T-lymphocyte interaction with fibronectin and vitronectin: Activated adhesion and cosignalling Immunology. 91: 186-192. PMID 9227315 DOI: 10.1046/J.1365-2567.1997.00237.X |
0.495 |
|
| 1997 |
Kedl RM, Mescher MF. Migration and Activation of Antigen-Specific CD8+ T Cells Upon in Vivo Stimulation with Allogeneic Tumor Journal of Immunology. 159: 650-663. PMID 9218580 |
0.483 |
|
| 1997 |
Mescher MF, Savelieva E. Stimulation of tumor-specific immunity using tumor cell plasma membrane antigen Methods: a Companion to Methods in Enzymology. 12: 155-164. PMID 9184379 DOI: 10.1006/Meth.1997.0466 |
0.411 |
|
| 1997 |
Deeths MJ, Mescher MF. B7-1-dependent co-stimulation results in qualitatively and quantitatively different responses by CD4+ and CD8+ T cells European Journal of Immunology. 27: 598-608. PMID 9079798 DOI: 10.1002/Eji.1830270305 |
0.612 |
|
| 1996 |
Anel A, O'Rourke AM, Kleinfeld AM, Mescher MF. T cell receptor and CD8-dependent tyrosine phosphorylation events in cytotoxic T lymphocytes: Activation of p56(lck) by CD8 binding to class I protein European Journal of Immunology. 26: 2310-2319. PMID 8898939 DOI: 10.1002/Eji.1830261007 |
0.526 |
|
| 1996 |
Ni HT, Deeths MJ, Mescher MF. Phosphatidylinositol 3 Kinase Activity Is Not Essential for B7-1-Mediated Costimulation of Proliferation or Development of Cytotoxicity in Murine T Cells Journal of Immunology. 157: 2243-2246. PMID 8805620 |
0.509 |
|
| 1996 |
Mescher MF, Rogers JD. Immunotherapy of established murine tumors with large multivalent immunogen and cyclophosphamide Journal of Immunotherapy. 19: 102-112. PMID 8732693 DOI: 10.1097/00002371-199603000-00003 |
0.322 |
|
| 1995 |
Mescher MF. Molecular interactions in the activation of effector and precursor cytotoxic T lymphocytes Immunological Reviews. 176-210. PMID 7493753 DOI: 10.1111/J.1600-065X.1995.Tb00689.X |
0.504 |
|
| 1994 |
O'Rourke AM, Mescher MF. Signals for activation of CD8-dependent adhesion and costimulation in CTLs Journal of Immunology. 152: 4358-4367. PMID 8157959 |
0.368 |
|
| 1994 |
Ybarrondo B, O'Rourke AM, Brian AA, Mescher MF. Contribution of lymphocyte function-associated-1/ intercellular adhesion molecule-1 binding to the adhesion/signaling cascade of cytotoxic T lymphocyte activation Journal of Experimental Medicine. 179: 359-363. PMID 7903682 DOI: 10.1084/Jem.179.1.359 |
0.526 |
|
| 1993 |
Kane KP, Mescher MF. Activation of CD8-Dependent Cytotoxic T Lymphocyte Adhesion and Degranulation by Peptide Class I Antigen Complexes Journal of Immunology. 150: 4788-4797. PMID 8496589 |
0.35 |
|
| 1993 |
O'Rourke AM, Ybarrondo B, Mescher MF. CD8 and antigen-specific T cell adhesion cascades Seminars in Immunology. 5: 263-270. PMID 8219104 DOI: 10.1006/Smim.1993.1030 |
0.551 |
|
| 1993 |
O'Rourke AM, Mescher MF. The roles of CD8 in cytotoxic T lymphocyte function Trends in Immunology. 14: 177-183. DOI: 10.1016/0167-5699(93)90283-Q |
0.597 |
|
| 1992 |
O'Rourke AM, Mescher MF. Cytotoxic T-lymphocyte activation involves a cascade of signalling and adhesion events Nature. 358: 253-255. PMID 1630493 DOI: 10.1038/358253A0 |
0.562 |
|
| 1992 |
Rogers J, Mescher MF. Augmentation of in vivo cytotoxic T lymphocyte activity and reduction of tumor growth by large multivalent immunogen Journal of Immunology. 149: 269-276. PMID 1607658 |
0.311 |
|
| 1992 |
Mescher MF. Surface contact requirements for activation of cytotoxic T lymphocytes Journal of Immunology. 149: 2402-2405. PMID 1527386 |
0.356 |
|
| 1992 |
O'Rourke AM, Mescher MF, Apgar JR. IgE receptor-mediated arachidonic acid release by rat basophilic leukemia (RBL-2H3) cells: Possible role in activating degranulation Molecular Immunology. 29: 1299-1308. PMID 1328876 DOI: 10.1016/0161-5890(92)90166-U |
0.341 |
|
| 1991 |
Mescher MF, O'Rourke AM, Champoux P, Kane KP. Equilibrium binding of cytotoxic T lymphocytes to class I antigen Journal of Immunology. 147: 36-41. PMID 2051026 |
0.324 |
|
| 1991 |
O'Rourke AM, Apgar JR, Kane KP, Martz E, Mescher MF. Cytoskeletal function in CD8- and T cell receptor-mediated interaction of cytotoxic T lymphocytes with class I protein Journal of Experimental Medicine. 173: 241-249. PMID 1898662 DOI: 10.1084/Jem.173.1.241 |
0.538 |
|
| 1991 |
Teitell M, Mescher MF, Olson CA, Littman DR, Kronenberg M. The thymus leukemia antigen binds human and mouse CD8. The Journal of Experimental Medicine. 174: 1131-8. PMID 1834760 DOI: 10.1084/Jem.174.5.1131 |
0.457 |
|
| 1990 |
Kane KP, Mescher MF. Antigen recognition by T cells: Quantitative effects of augmentation by antibodies providing accessory interactions Journal of Immunology. 144: 824-829. PMID 2295819 |
0.377 |
|
| 1990 |
O'Rourke AM, Mescher MF, Webb SR. Activation of polyphosphoinositide hydrolysis in T cells by H-2 alloantigen but not MLS determinants Science. 249: 171-174. PMID 2164711 DOI: 10.1126/Science.2164711 |
0.612 |
|
| 1990 |
O'Rourke AM, Mescher MF. T-cell receptor-activated adhesion systems Current Opinion in Cell Biology. 2: 888-893. PMID 2128023 DOI: 10.1016/0955-0674(90)90088-V |
0.335 |
|
| 1990 |
O'Rourke AM, Rogers J, Mescher MF. Activated CD8 binding to class I protein mediated by the T-cell receptor results in signalling Nature. 346: 187-189. PMID 2114552 DOI: 10.1038/346187A0 |
0.591 |
|
| 1989 |
Kane KP, Vitiello A, Sherman LA, Mescher MF. Cytolytic T-lymphocyte response to isolated class I H-2 proteins and influenza peptides Nature. 340: 157-159. PMID 2786997 DOI: 10.1038/340157A0 |
0.389 |
|
| 1989 |
Kane KP, Champoux P, Mescher MF. Solid-phase binding of class I and II MHC proteins: Immunoassay and T cell recognition Molecular Immunology. 26: 759-768. PMID 2478875 DOI: 10.1016/0161-5890(89)90036-9 |
0.359 |
|
| 1989 |
Kane KP, Sherman LA, Mescher MF. Molecular interactions required for triggering alloantigen-specific cytolytic T lymphocytes Journal of Immunology. 142: 4153-4160. PMID 2470815 |
0.304 |
|
| 1988 |
Kane KP, Goldstein SAN, Mescher MF. Class I alloantigen is sufficient for cytolytic T lymphocyte binding and transmembrane signaling European Journal of Immunology. 18: 1925-1929. PMID 3265386 DOI: 10.1002/Eji.1830181209 |
0.403 |
|
| 1988 |
O'Rourke AM, Mescher MF. T cell receptor-mediated signaling occurs in the absence of inositol phosphate production Journal of Biological Chemistry. 263: 18594-15897. PMID 3143713 |
0.352 |
|
| 1988 |
Goldstein SAN, Mescher MF. T cell recognition of nonpolymorphic determinants on H-2 class I molecules Journal of Immunology. 140: 3707-3711. PMID 2453553 |
0.355 |
|
| 1987 |
Ostergaard HL, Kane KP, Mescher MF, Clark WR. Cytotoxic T lymphocyte mediated lysis without release of serine esterase Nature. 330: 71-72. PMID 3118212 DOI: 10.1038/330071A0 |
0.358 |
|
| 1987 |
Goldstein SAN, Mescher MF. Cytotoxic T cell activation by Class I protein on cell-size artificial membranes: Antigen density and Lyt-2/3 function Journal of Immunology. 138: 2034-2043. PMID 2951431 |
0.345 |
|
| 1986 |
Goldstein SAN, Mescher MF. Cell-sized, supported artificial membranes (pseudocytes): Response of precursor cytotoxic T lymphocytes to class I MHC proteins Journal of Immunology. 137: 3383-3392. PMID 3491134 |
0.411 |
|
| 1986 |
Herrmann SH, Mescher MF. The requirements for antigen multivalency in class I antigen recognition and triggering of primed precursor cytolytic T lymphocytes Journal of Immunology. 136: 2816-2825. PMID 3082973 |
0.399 |
|
| 1985 |
Goldstein SAN, Mescher MF. Carbohydrate moieties of major histocompatibility complex class I alloantigens are not required for their recognition by T lymphocytes Journal of Experimental Medicine. 162: 1381-1386. PMID 3876403 DOI: 10.1084/Jem.162.4.1381 |
0.461 |
|
| 1985 |
Weinberger O, Herrmann SH, Greenstein JL, Mescher MF, Burakoff SJ. The ability of Ia and H-2Kk-bearing membranes to replace the antigen-presenting cell in an H-2Kk allogeneic cytotoxic T cell response. European Journal of Immunology. 15: 1013-8. PMID 2932336 DOI: 10.1002/Eji.1830151010 |
0.646 |
|
| 1985 |
Falo LD, Sullivan K, Benacerraf B, Mescher MF, Rock KL. Analysis of antigen presentation by metabolically inactive accessory cells and their isolated membranes. Proceedings of the National Academy of Sciences of the United States of America. 82: 6647-51. PMID 2413442 DOI: 10.1073/Pnas.82.19.6647 |
0.375 |
|
| 1984 |
Stallcup KC, Dawson A, Mescher MF. Growth-inhibitory activity of lymphoid cell plasma membranes. I. Inhibition of lymphocyte and lymphoid tumor cell growth Journal of Cell Biology. 99: 1221-1226. PMID 6434546 DOI: 10.1083/Jcb.99.4.1221 |
0.369 |
|
| 1984 |
Stallcup KC, Burakoff SJ, Mescher MF. Inhibition of normal lymphocyte responses by cell membranes Cellular Immunology. 89: 144-150. PMID 6333285 DOI: 10.1016/0008-8749(84)90205-3 |
0.575 |
|
| 1984 |
Stallcup KC, Burakoff SJ, Mescher MF. Growth-inhibitory activity of lymphoid cell plasma membranes. II. Partial characterization of the inhibitor Journal of Cell Biology. 99: 1227-1234. PMID 6332814 DOI: 10.1083/Jcb.99.4.1227 |
0.593 |
|
| 1984 |
Sullivan CP, Rock K, Germain RN, Mescher MF. Structural and functional analysis of T cell responses to Ia antigens Federation Proceedings. 43. |
0.409 |
|
| 1983 |
Mescher MF, Stallcup KC, Sullivan CP. Purification of murine MHC antigens by monoclonal antibody affinity chromatography Methods in Enzymology. 86-109. PMID 6574303 DOI: 10.1016/0076-6879(83)92011-6 |
0.301 |
|
| 1982 |
Mescher MF, Balk SP, Burakoff SJ, Herrmann SH. Cytolytic T lymphocyte recognition of subcellular antigen Advances in Experimental Medicine and Biology. 146: 41-55. PMID 6980567 DOI: 10.1007/978-1-4684-8959-0_3 |
0.614 |
|
| 1982 |
Herrmann SH, Weinberger O, Burakoff SJ, Mescher MF. Analysis of the two-signal requirement for precursor cytolytic T lymphocyte activation using H-2K(k) in liposomes Journal of Immunology. 128: 1968-1974. PMID 6801126 |
0.305 |
|
| 1982 |
Germain RN, Mayer SV, Mescher MF. Role of I-region gene products in T cell activation. I. Stimulation of T lymphocyte proliferative responses by subcellular membrane preparations containing Ia alloantigens Journal of Immunology. 128: 506-511. PMID 6172491 |
0.475 |
|
| 1981 |
Burakoff SJ, Weinberger O, Herrmann SH, Mescher MF. Cellular interactions in the regulation of the cytolytic T-lymphocyte response: The effect of suboptimal antigen dose Transplantation Proceedings. 13: 1039-1041. PMID 6973854 |
0.328 |
|
| 1981 |
Weinberger O, Herrmann S, Mescher MF, Benacerraf B, Burakoff SJ. Cellular interactions in the generation of cytolytic T lymphocyte responses. Analysis of the helper T cell pathway. European Journal of Immunology. 11: 405-11. PMID 6973476 DOI: 10.1002/Eji.1830110511 |
0.69 |
|
| 1981 |
Weinberger O, Herrmann S, Mescher MF, Benacerraf B, Burakoff SJ. Antigen-presenting cell function in induction of helper T cells for cytotoxic T-lymphocyte responses: evidence for antigen processing. Proceedings of the National Academy of Sciences of the United States of America. 78: 1796-9. PMID 6972042 DOI: 10.1073/Pnas.78.3.1796 |
0.705 |
|
| 1981 |
Balk SP, Mescher MF. Specific reversal of cytolytic T lymphocyte-target cell interaction Journal of Supramolecular and Cellular Biochemistry. 16: 43-52. PMID 6795359 |
0.387 |
|
| 1981 |
Balk SP, Mescher MF. Specific reversal of cytolytic T cell-target cell functional binding is induced by free target cells Journal of Immunology. 127: 51-57. PMID 6787131 |
0.336 |
|
| 1980 |
Burakoff SJ, Reiss CS, Finberg R, Mescher MF. Cell-mediated immunity to viral glycoproteins Reviews of Infectious Diseases. 2: 62-78. PMID 6994203 DOI: 10.1093/Clinids/2.1.62 |
0.601 |
|
| 1980 |
Weinberger O, Herrmann SH, Mescher MF, Benacerraf B, Burakoff SJ. Cellular interactions in the generation of cytolytic T lymphocyte responses: role of Ia-positive splenic adherent cells in presentation in H-2 antigen. Proceedings of the National Academy of Sciences of the United States of America. 77: 6091-5. PMID 6969401 DOI: 10.1073/Pnas.77.10.6091 |
0.691 |
|
| 1980 |
Sherman L, Burakoff SJ, Mescher MF. Induction of allogeneic cytolytic T lymphocytes by partially purified membrane glycoproteins Cellular Immunology. 51: 141-150. PMID 6767550 DOI: 10.1016/0008-8749(80)90244-0 |
0.569 |
|
| 1980 |
Burakoff SJ, Weinberger O, Herrmann SH, Mescher MF. The use of purified H-2 antigens to define the helper T cell pathway involved in cytolytic T lymphocyte induction Behring Institute Mitteilungen. 118-122. |
0.436 |
|
| 1979 |
Sherman L, Mescher MF, Burakoff SJ. The induction of cytolytic T lymphocytes with syngeneic trinitrophenyl-coupled membranes Journal of Immunology. 123: 501-502. PMID 312884 |
0.349 |
|
| 1979 |
Finberg R, Mescher M, Burakoff SJ. The induction of virus-specific cytotoxic T lymphocytes with solubilized viral and membrane proteins. The Journal of Experimental Medicine. 148: 1620-7. PMID 214512 DOI: 10.1084/Jem.148.6.1620 |
0.559 |
|
| 1978 |
Mescher MF, Strominger JL. Glycosylation of the surface glycoprotein of Halobacterium salinarium via a cyclic pathway of lipid-linked intermediates Febs Letters. 89: 37-41. PMID 658399 DOI: 10.1016/0014-5793(78)80517-1 |
0.307 |
|
| 1978 |
Engelhard VH, Strominger JL, Mescher M, Burakoff S. Induction of secondary cytotoxic T lymphocytes by purified HLA-A and HLA-B antigens reconstituted into phospholipid vesicles Proceedings of the National Academy of Sciences of the United States of America. 75: 5688-5691. PMID 310125 DOI: 10.1073/Pnas.75.11.5688 |
0.732 |
|
| 1978 |
Mescher M, Sherman L, Lemonnier F, Burakoff S. The induction of secondary cytolytic T lymphocytes by solubilized membrane proteins. The Journal of Experimental Medicine. 147: 946-51. PMID 305464 DOI: 10.1084/Jem.147.3.946 |
0.638 |
|
| 1976 |
Mescher MF, Strominger JL. Purification and characterization of a prokaryotic glycoprotein from the cell envelope of Halobacterium salinarium Journal of Biological Chemistry. 251: 2005-2014. PMID 1270419 |
0.3 |
|
| 1976 |
Mescher MF, Strominger JL. Structural (shape maintaining) role of the cell surface glycoprotein of Halobacterium salinarium Proceedings of the National Academy of Sciences of the United States of America. 73: 2687-2691. PMID 1066681 DOI: 10.1073/Pnas.73.8.2687 |
0.463 |
|
| 1974 |
Mescher MF, Strominger JL, Watson SW. Protein and Carbohydrate Composition of the Cell Envelope of Halobacterium salinarium1 Journal of Bacteriology. 120: 945-954. DOI: 10.1128/jb.120.2.945-954.1974 |
0.394 |
|
| Show low-probability matches. |
